20 results
8-K
EX-99.1
xuinf kyn9c9qklbqx
29 Sep 22
GB2064 Shows Reduction in Fibrosis of the Bone Marrow in Patients with Myelofibrosis, Validating LOXL2 as a Clinical Fibrosis Target
7:00am
8-K
EX-99.1
2qlglq
5 Jan 22
Regulation FD Disclosure
4:02pm
10-K
oudpm
29 Mar 21
Annual report
6:03am
8-K
EX-99.1
6qa9oj
5 Jan 21
Results of Operations and Financial Condition
4:31pm
10-Q
yhel7ks6803j m9i
11 Dec 20
Quarterly report
7:30am
424B4
bjmxejr hv0zz
30 Oct 20
Prospectus supplement with pricing info
4:31pm
S-1/A
jaook8 66ojct31si
22 Oct 20
IPO registration (amended)
6:13am
S-1
zhw aemee0jgw6g1
7 Oct 20
IPO registration
5:01pm
DRS
p089l 1zsks7
2 Sep 20
Draft registration statement
12:00am
- Prev
- 1
- Next